Gut Microbes May Impact Autoimmunity

Researchers show that the prevalence of one genus of bacteria correlates with the onset of rheumatoid arthritis.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PrevotellaBMC MICROBIOLOGY, YAMANAKA ET AL.The more scientists learn about the gut microbiome, the more roles it seems to play. New evidence from researchers at the New York University (NYU) School of Medicine, the Memorial Sloan-Kettering Cancer Center in New York, and the Harvard School of Public Health in Cambridge, Massachusetts, shows a correlation between onset of rheumatoid arthritis (RA) with the prevalence of a certain microbe—Prevotella copri. The work was published this week (November 5) in eLife.

“It's been suspected for years and years . . . that the development of autoimmune diseases like arthritis is dependent on the gut microbiota,” Diane Mathis, a professor of microbiology and immunobiology at Harvard Medical School in Boston, Massachusetts, who was not involved in the work, told ScienceNOW. “It’s a very striking finding,” she added.

The researchers sequenced bacterial genes in 114 fecal samples from patients who had recently been diagnosed with RA, patients who had been treated for RA, patients with a different type of autoimmune arthritis (psoriatic), and healthy controls. They found P. copri in 75 percent of the samples from patients who had just been diagnosed with RA, but only in 21 percent of samples from healthy controls, 38 percent of samples ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies